MELISSA LANGHALS: Open Payments
NPI 1447718168 · KALIDA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 57 payments from 13 companies in 2025. Trend: 2023 $437 · 2024 $828 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Lucid Diagnostics Inc. | 12 | $234 |
| Novo Nordisk Inc | 24 | $210 |
| Lilly USA, LLC | 5 | $81 |
| ABBVIE INC. | 4 | $65 |
| Exact Sciences Corporation | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $29 |
| SANOFI PASTEUR INC. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| PFIZER INC. | 1 | $17 |
Products named: Ozempic, MOUNJARO, Wegovy, VRAYLAR, The Cologuard Plus Collection Kit, XIFAXAN, Rybelsus, GEMTESA.
Industry payments across OH — which companies pay providers there.
